SENTRY is an Internet-based collection and dissemination system designed to help identify new, primarily synthetic drug-related behaviors at an early stage, evaluate their likely importance, track their development, and share these data with authorized users in a real-time environment.
SENTRY is operated by NDIC in coordination with the Office of National Drug Control Policy (ONDCP) and supports the National Synthetic Drugs Action Plan.
SENTRY focuses primarily on synthetic drugs that are typically produced via a chemical process, such as LSD (lysergic acid diethylamide), MDMA (3,4-methylenedioxymethamphetamine, also known as ecstasy), and methamphetamine. The system will also be used to monitor prescription drugs, over-the-counter medications, botanical substances and extracts, and chemicals and products involved in the manufacturing of synthetic drugs.